Skip to content

Cipla stock jumps to all-time high; Nuvama raises target price, sees 18% upside

Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.

Read More

​ Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts. Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.  Moneycontrol Latest News Read More  

Leave a Reply

en_USEnglish